Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT06683950

Recruiting

Switching to Aflibercept 8mg in Patients Showing Limited Response to Previous Treatment

Age-related Macular Degeneration (ARMD)
NCT06025916

Recruiting

Postpartum Hemorrhage Reduction With Oral Tranexamic Acid: a Clinical Trial (PROTECT)

PPH
NCT05956769

Not yet recruiting

Goal-directed vs Preemptive Tranexamic Acid Administration in Total Hip Arthroplasty

Arthritis of Hip
NCT05297292

Recruiting

A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD

Wet Age-related Macular Degeneration
NCT04898712

Not yet recruiting

Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma -2 (TRACE-2)

Chronic Subdural Hematoma
NCT06908876

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME）

Diabetic Macular Oedema
NCT05972473

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects with NAMD

Neovascular Age-related Macular Degeneration
NCT04707625

Terminated

Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment

Retinal Vein Occlusion
NCT05710471

Completed

Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E

Age-Related Macular Degeneration
NCT04146493

Completed

Heparin-Binding Protein and Heparins (HepHep)

Cardiovascular Diseases | Vascular Disease, Peripheral | Thromboprophylaxis
NCT01683955

Completed

Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty

Osteoarthritis, Hip | Acute Blood Loss Anemia
NCT03426124

Completed

An International Pulmonary Embolism Registry Using EKOS (KNOCOUT PE)

Pulmonary Embolism and Thrombosis
NCT02157077

Completed

Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration (ARI2)

Eye Diseases | Macular Degeneration | Retinal Degeneration | Retinal Diseases | Wet Macular Degeneration
NCT03090880

Terminated

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (PROVE)

Venous Thromboembolism | Lung Neoplasm
NCT03097068

Completed

Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis

Diabetic Macular Edema
NCT04588948

Withdrawn

A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema (DRAW-2)

Diabetic Macular Edema
NCT04919096

Withdrawn

Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration

Wet Age-related Macular Degeneration
NCT05324592

Completed

Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema

Diabetic Macular Edema
NCT03297684

Active, not recruiting

Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection

Diabetic Macular Edema
NCT02840097

Completed

Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: A Pilot and Feasibility Study (TIC-TOC)

Wounds and Injuries | Brain Injuries | Hemorrhage
NCT02444572

Completed

Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® (ENOXACARE)

Gastrointestinal Neoplasms | Thromboembolic Event
NCT04338126

Withdrawn

Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients (TCInpatient)

COVID19
NCT00161720

Completed

Retrospective Study to Capture Dosing and Treatment Outcome Data in Participants With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND

Protein C Deficiency
NCT01207921

Completed

Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma

Hodgkin Disease
NCT04653623

Unknown

Effect of Tranexamic Acid on Blood Loss After High Tibial Osteotomy

Osteoarthritis, Knee
NCT02860858

Completed

Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)

Symtomatic Macular Polypoidal Choroidal Vasculopathy
NCT04288232

Completed

Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan

Center-involved Diabetic Macular Edema
NCT00432796

Unknown

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Stroke
NCT02370888

Terminated

Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease (UF-BMT-MRD-101)

Myelodysplastic Syndromes | Leukemia, Myeloid
NCT03797729

Unknown

Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients.

ST Elevation Myocardial Infarction
NCT04170088

Completed

Comparison of Efficacy of Tranexamic Acid Mesotherapy Versus 0.9% Normal Saline for Melasma

Effect of Drugs | Adverse Effects of Medical Drugs
NCT03823417

Withdrawn

The Effectiveness Of Intravenous TXA on Reducing Perioperative Blood Loss For Patients Undergoing PAO

Bleeding
NCT02299336

Completed

Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial

Diabetic Macular Edema
NCT01965730

Terminated

Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery (EACA)

Aortic Disease
NCT02979665

Completed

Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema

Diabetic Macular Edema
NCT03934047

Unknown

Visual Field Infiltration of Tranexamic Acid Reduced the Blood Loss in Total Knee Arthroplasty

Total Knee Arthroplasty
NCT03609996

Unknown

Retrospective Review of Proliferative Diabetic Retinopathy Patients

Proliferative Diabetic Retinopathy
NCT01896284

Completed

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor (MACBETH)

Wet Macular Degeneration
NCT00963105

Completed

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Relapsed or Refractory Chronic Lymphocytic Leukemia
NCT03115255

Completed

Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab

Infant, Premature, Diseases
NCT02072408

Completed

Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy Without Active Polyp
NCT02302989

Completed

Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration (PROTECT)

Age-related Macular Degeneration
NCT01773954

Completed

Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration (ATLAS)

Age-Related Macular Degeneration | Macular Degeneration
NCT00585182

Completed

Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT

Obesity | Venous Thrombosis | Anticoagulants
NCT01657669

Unknown

Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results

Age Related Macular Degeneration
NCT02924987

Unknown

Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema (Eylea)

Diabetic Macular Edema
NCT02134457

Completed

Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity (CARE-ROP)

Retinopathy of Prematurity (ROP)
NCT02374398

Completed

Clinical Trial Comparing Tranexamic Acid (TXA) With Aquamantys Sealer in Total Knee Arthroplasty (TKA)

Blood Loss
NCT01600053

Terminated

Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia
NCT01401322

Terminated

Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Leukemia | Relapsed Adult Acute Lymphocytic Leukemia

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations